Rather than focusing exclusively on traditional calorie-based explanations for weight fluctuation, more consumers are considering internal microbial balance as a contributing factor
More practically, the drugs suppress appetite, slow digestion, and boost satiety, which can lead to quick weight loss because people on them, well, just dont feel the urge to eat
International Diabetes Federation IDF Diabetes Atlas
Wegovy is a GLP-1 receptor agonist anti-obesity medication that has several cardiovascular benefits, based on data from the SELECT Trial published last fall in The New England Journal of Medicine
GLP-1 s also inhibit gastric emptying and induce gastroparesis, which induces satiety and reduces appetite and food intake, therefore limiting weight gain [1]